Spain· ES:76730
PLIAGLIS 70 MG/G + 70 MG/G CREMA
A medicinal product containing lidocaina + tetracaina, registered in Spain by Industrial Farmaceutica Cantabria S.A..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- lidocaina + tetracaina
- Manufacturer
- Industrial Farmaceutica Cantabria S.A.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lidocaina + tetracaina in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBlockaidSofTap Inc
- CzechiaPLIAGLISEgis Pharmaceuticals PLC, Budapešť
- GermanyPliaglisCroma Pharma Gmbh
- United KingdomPliaglis 70mg/g / 70mg/g creamCroma-Pharma GmbH
- NetherlandsPliaglis 70 mg/g + 70 mg/g crèmeCroma Pharma GmbH
- CanadaPLIAGLISSCIENCES DE LA PEAU CRESCITA INC. / CRESCITA SKIN SCIENCES INC.
- NorwayRapydanEurocept International B.V
- PolandPliaglisEgis Pharmaceuticals PLC
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Pliaglis, Rapydan
- Belgium · Pliaglis, Rapydan
- Bulgaria · Плиаглис
- Czechia · Pliaglis
- Germany · Pliaglis, Rapydan
- Denmark · Pliapel, Ralydan
- United Kingdom (Northern Ireland) · Pliaglis, Rapydan
- Greece · Pliaglis
- Hungary · Pliapeel
- Ireland · Pliaglis
- Italy · Pliaglis
- Lithuania · Cessolute
- Luxembourg · Pliaglis, Rapydan
- Latvia · Cessolute
- Netherlands · Pliaglis, Rapydan
- Norway · Pliapel, Rapydan
- Poland · Pliaglis
- Portugal · Pliaglis
- Sweden · Rapydan
- Slovakia · Pliaglis
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8153bba0-04dc-4d08-810f-229f9f170be6 GET /v1/drugs/8153bba0-04dc-4d08-810f-229f9f170be6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1352191155000,\"susp\":1729503852000}",
"nregistro": "76730",
"substance": "lidocaina + tetracaina"
}See everything about lidocaina + tetracaina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.